------------------------------------------
 详细处方信息以本药内容附件PDF文件（200982703110017.pdf）的“原文Priscribing Information”为准
----------------------------------------

Nasacort AQ Nasal Spray is indicated for the relief of seasonal and year-round nasal allergy symptoms in adults and children as young as 2 years.
Do not take Nasacort AQ if you are allergic to any of its ingredients.
Patients using corticosteroids that weaken the immune system are more susceptible to infections and should avoid exposure to chickenpox or measles.
Talk with your doctor if you recently had nasal ulcers, nasal surgery, or trauma.
Talk with your doctor if you have a history of eye problems or experience a change in vision.
Intranasal corticosteroids, including Nasacort AQ, may cause slowed growth in children.
The most common side effects include sore throat, nose bleeds, cough, flu-like symptoms, and headache. Infections of nose and throat may occur.
Use only as directed by your health care provider.

FDA批准變應性鼻炎用藥曲安奈德

　　安萬特公司近日宣布，FDA已經批准了NASACORT AQ (triamcinolone acetonide，曲安奈德)用于治療季節性或常年變應性鼻炎，可用于成人與6歲以上的兒童。
　　Nasacort AQ起效快速，12～16小時即可緩解症狀，該品在治療季節性花粉過敏症時與Flonase等效。Nasacort AQ鼻噴霧劑無味，不含有刺激性氣味的乙醇。
　　對于年齡在12歲以上的患者，推荐開始時的最大劑量為一日220μg，也就是對每個鼻孔每天按2銜。對6～12歲的患者，推荐初始劑量為一日110μg，即每鼻孔1銜。
　　該品的安全性和有效性評估來自十項雙盲安慰劑對照臨床研究，為期多在2～4周，納入季節性或常年變應性鼻炎患者，總體而言，與安慰劑組比較，本品顯著緩解了症狀，包括噴嚏、悶熱、搔痒和鼻腔排泄物過多。
　　使用Nasacort AQ不嗜睡，不產生依賴性，患者最好每天連續使用，一周左右的時間將達到最佳治療效果，本品不良反應發生率低，常見的主要有咽炎、鼻出血和咳嗽。

------------------------------------------
 详细处方信息以本药内容附件PDF文件（200982703110017.pdf）的“原文Priscribing Information”为准
----------------------------------------

20090827更新